|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1054905613 |
| 003 |
OCoLC |
| 005 |
20231120010316.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
180928s2018 mau o 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d EBLCP
|d OCLCF
|d UKMGB
|d YDX
|d NRC
|d OCLCQ
|d MERER
|d OCLCQ
|d LQU
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d SFB
|d GZM
|d OCLCO
|
| 016 |
7 |
|
|a 019064443
|2 Uk
|
| 019 |
|
|
|a 1055044354
|a 1055262664
|a 1105189316
|a 1105565710
|
| 020 |
|
|
|a 9780444641984
|q (electronic bk.)
|
| 020 |
|
|
|a 044464198X
|q (electronic bk.)
|
| 020 |
|
|
|z 9780444641991
|q (print)
|
| 020 |
|
|
|z 0444641998
|
| 035 |
|
|
|a (OCoLC)1054905613
|z (OCoLC)1055044354
|z (OCoLC)1055262664
|z (OCoLC)1105189316
|z (OCoLC)1105565710
|
| 050 |
|
4 |
|a RA1220.3
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MMGT
|2 bicssc
|
| 072 |
|
7 |
|a PSD
|2 bicssc
|
| 082 |
0 |
4 |
|a 571.9/5
|2 23
|
| 245 |
0 |
0 |
|a Advances in molecular toxicology.
|n Volume 12 /
|c edited by James C. Fishbein, Jacqueline M. Heilman.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press, an imprint of Elsevier,
|c 2018.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Molecular Toxicology Ser. ;
|v v. Volume 12
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed September 28, 2018).
|
| 505 |
0 |
|
|a Front Cover; Advances in Molecular Toxicology; Copyright; Contents; Contributors; Preface; Chapter One: Toxicology of Inorganic Carcinogens; 1. Introduction; 2. Known Human Carcinogens; 2.1. Arsenic; 2.1.1. Exposure; 2.1.2. ADME properties; 2.1.3. Toxicity; 2.1.4. Mechanisms of toxicity; 2.1.5. Carcinogenicity; 2.2. Beryllium; 2.2.1. Exposure; 2.2.2. ADME properties; 2.2.3. Toxicity; 2.2.4. Carcinogenicity; 2.3. Cadmium; 2.3.1. Exposure; 2.3.2. ADME properties; 2.3.3. Toxicity; 2.3.4. Mechanisms of toxicity; 2.3.5. Carcinogenicity; 2.4. Chromium; 2.4.1. Exposure; 2.4.2. ADME properties.
|
| 505 |
8 |
|
|a 2.4.3. Toxicity2.4.4. Carcinogenesis; 2.5. Nickel; 2.5.1. Exposure; 2.5.2. ADME properties; 2.5.3. Toxicity; 2.5.4. Carcinogenicity; 3. Probably Carcinogenic to Humans; 3.1. Antimony; 3.1.1. Exposure; 3.1.2. ADME properties; 3.1.3. Toxicity; 3.1.4. Carcinogenicity; 3.2. Cobalt; 3.2.1. Exposure; 3.2.2. ADME properties; 3.2.3. Toxicity; 3.2.4. Carcinogenicity; 3.3. Indium; 3.3.1. Exposure; 3.3.2. ADME properties; 3.3.3. Toxicity; 3.3.4. Carcinogenesis; 3.4. Lead; 3.4.1. Exposure; 3.4.2. ADME properties; 3.4.3. Toxicity; 3.4.4. Carcinogenesis; 3.5. Vanadium; 3.5.1. Exposure.
|
| 505 |
8 |
|
|a 4.9. Role of signaling pathways5. Physicochemical Determinants of CNT-Induced Fibrosis; 5.1. Metal content; 5.2. Surface functionalization; 5.3. Dispersion status; 5.4. Length; 6. Conclusions; Acknowledgments; Disclaimers and Declaration of Interest; References; Chapter Three: Chemopreventive Role of Dietary Phytochemicals in Colorectal Cancer; 1. Introduction; 2. Dietary Phytochemicals; 2.1. Quercetin; 2.1.1. Chemical composition and molecular structure; 2.1.2. Sources; 2.1.3. Molecular targets; 2.1.4. Clinical trials; 2.2. Capsaicin; 2.2.1. Chemical composition and molecular structure.
|
| 505 |
8 |
|
|a 2.2.2. Sources2.2.3. Molecular targets; 2.2.4. Clinical trials; 2.3. Epigallocatechin-3-gallate; 2.3.1. Chemical composition and molecular structure; 2.3.2. Sources; 2.3.3. Molecular targets; 2.3.4. Clinical trials; 2.4. Resveratrol; 2.4.1. Chemical composition and molecular structure; 2.4.2. Source; 2.4.3. Molecular targets; 2.4.4. Clinical trials; 2.5. Sulforaphane; 2.5.1. Chemical composition and molecular structure; 2.5.2. Sources; 2.5.3. Molecular targets; 2.5.4. Clinical trials; 2.6. [6]-gingerol; 2.6.1. Chemical composition and molecular structure; 2.6.2. Source.
|
| 650 |
|
0 |
|a Molecular toxicology.
|
| 650 |
|
6 |
|a Toxicologie mol�eculaire.
|0 (CaQQLa)201-0197805
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Molecular toxicology
|2 fast
|0 (OCoLC)fst01024862
|
| 700 |
1 |
|
|a Fishbein, James C.,
|e editor.
|
| 700 |
1 |
|
|a Heilman, Jacqueline M.,
|d 1979-
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Heilman, Jacqueline M.
|t Advances in Molecular Toxicology.
|d San Diego : Elsevier Science & Technology, �2018
|z 9780444641991
|
| 830 |
|
0 |
|a Advances in Molecular Toxicology Ser.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18720854/12
|z Texto completo
|
